The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence

Hallmarks of Cancer: The Next Generation

Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590

PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer

Hartkopf, A. D., Taran, F., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,989

The hallmarks of cancer

Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

Hodi, F. S., O'Day, S. J., McDermott, D. F., Weber, R. W., Sosman, J. A., Haanen, J. B., Gonzalez, R., Robert, C., Schadendorf, D., Hassel, J. C., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003466 · Cited by 15,155

Angiogenesis in cancer and other diseases

Carmeliet, P., & Jain, R. K. (2000) · Nature · doi:10.1038/35025220 · Cited by 9,070

Pattern Recognition Receptors and Inflammation

Takeuchi, O., & Akira, S. (2010) · Cell · doi:10.1016/j.cell.2010.01.022 · Cited by 8,895

Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy

Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527

Hypoxia — a key regulatory factor in tumour growth

Harris, A. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc704 · Cited by 5,177

Fibroblasts in cancer

Kalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538

Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma

Robert, C., Thomas, L., Bondarenko, I., O'Day, S., Weber, J., Garbe, C., Lebbe, C., Baurain, J.-F., Testori, A., Grob, J.-J., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1104621 · Cited by 4,496

Cellular and molecular mechanisms of fibrosis

Wynn, T. (2008) · The Journal of Pathology · doi:10.1002/path.2277 · Cited by 4,495

Untitled work

(1989) · PubMed · Cited by 3,343

The Three Es of Cancer Immunoediting

Dunn, G. P., Old, L. J., & Schreiber, R. D. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104803 · Cited by 3,235

Immunogenic cell death and DAMPs in cancer therapy

Krysko, D. V., Garg, A. D., Kaczmarek, A., Krysko, O., Agostinis, P., & Vandenabeele, P. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3380 · Cited by 3,223

Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

Apetoh, L., Ghiringhelli, F., Tesniere, A., Obeid, M., Ortiz, C., Criollo, A., Mignot, G., Maiuri, M. C., Ullrich, E., Saulnier, P., et al. (2007) · Nature Medicine · doi:10.1038/nm1622 · Cited by 3,056

Exploiting tumour hypoxia in cancer treatment

Brown, J. M., & Wilson, W. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1367 · Cited by 2,828

Influence of tumour micro-environment heterogeneity on therapeutic response

Junttila, M. R., & de Sauvage, F. J. (2013) · Nature · doi:10.1038/nature12626 · Cited by 2,694

Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival

Özdemir, B. C., Pentcheva-Hoang, T., Carstens, J. L., Zheng, X., Wu, C.-C., Simpson, T. R., Laklai, H., Sugimoto, H., Kahlert, C., Novitskiy, S. V., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.04.005 · Cited by 2,681

Molecular regulation of vessel maturation

Jain, R. K. (2003) · Nature Medicine · doi:10.1038/nm0603-685 · Cited by 2,594

Irradiation and anti–PD-L1 treatment synergistically promote antitumor immunity in mice

Deng, L., Liang, H. L., Burnette, B., Beckett, M., Darga, T. E., Weichselbaum, R. R., & Fu, Y. (2014) · Journal of Clinical Investigation · doi:10.1172/jci67313 · Cited by 2,119

Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma

Postow, M. A., Callahan, M. K., Barker, C. A., Yamada, Y. J., Yuan, J. D., Kitano, S., Mu, Z., Rasalan, T. S., Adamow, M. J., Ritter, E., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1112824 · Cited by 2,105

Molecular Signature of CD8+ T Cell Exhaustion during Chronic Viral Infection

Wherry, E. J., Ha, S.-J., Kaech, S. M., Haining, W. N., Sarkar, S., Kalia, V., Subramaniam, S., Blattman, J. N., Barber, D. L., & Ahmed, R. (2007) · Immunity · doi:10.1016/j.immuni.2007.09.006 · Cited by 2,103

Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity

Sakuishi, K., Apetoh, L., Sullivan, J. M., Blazar, B. R., Kuchroo, V. K., & Anderson, A. C. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100643 · Cited by 2,072

A cytokine-mediated link between innate immunity, inflammation, and cancer

Lin, W.-W., & Karin, M. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31537 · Cited by 1,940

Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4

Qureshi, O. S., Zheng, Y., Nakamura, K., Attridge, K., Manzotti, C., Schmidt, E. M., Baker, J., Jeffery, L. E., Kaur, S., Briggs, Z., et al. (2011) · Science · doi:10.1126/science.1202947 · Cited by 1,860

Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases

Carmeliet, P., & Jain, R. K. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3455 · Cited by 1,740

Fractionated but Not Single-Dose Radiotherapy Induces an Immune-Mediated Abscopal Effect when Combined with Anti–CTLA-4 Antibody

Dewan, M. Z., Galloway, A. E., Kawashima, N., Dewyngaert, J. K., Babb, J. S., Formenti, S. C., & Demaria, S. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0265 · Cited by 1,678

Normalization of the Vasculature for Treatment of Cancer and Other Diseases

Goel, S., Duda, D. G., Xu, L., Munn, L. L., Boucher, Y., Fukumura, D., & Jain, R. K. (2011) · Physiological Reviews · doi:10.1152/physrev.00038.2010 · Cited by 1,605

Tumor Response to Radiotherapy Regulated by Endothelial Cell Apoptosis

Garcı́a-Barros, M., Paris, F., Cordon‐Cardo, C., Lyden, D. C., Rafii, S., Haimovitz‐Friedman, A., FUKS, Z. Y., & Kolesnick, R. (2003) · Science · doi:10.1126/science.1082504 · Cited by 1,591

VEGF and the quest for tumour angiogenesis factors

Ferrara, N. (2002) · Nature Reviews Cancer · doi:10.1038/nrc909 · Cited by 1,536

Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma

Sekulić, A., Migden, M. R., Oro, A. E., Dirix, L. Y., Lewis, K. D., Hainsworth, J. D., Solomon, J. A., Yoo, S. S., Arron, S. T., Friedlander, P. A., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113713 · Cited by 1,460

Oncolytic virotherapy

Russell, S. J., Peng, K.-W., & Bell, J. C. (2012) · Nature Biotechnology · doi:10.1038/nbt.2287 · Cited by 1,428

Molecular Signature of CD8+ T Cell Exhaustion during Chronic Viral Infection

Wherry, E. J., Ha, S., Kaech, S. M., Haining, W. N., Sarkar, S., Kalia, V., Subramaniam, S., Blattman, J. N., Barber, D. L., & Ahmed, R. (2007) · Immunity · doi:10.1016/j.immuni.2007.11.006 · Cited by 1,355

Endothelial Apoptosis as the Primary Lesion Initiating Intestinal Radiation Damage in Mice

Paris, F., FUKS, Z. Y., Kang, A. D., Capodieci, P., Juan, G., Ehleiter, D., Haimovitz‐Friedman, A., Cordon‐Cardo, C., & Kolesnick, R. (2001) · Science · doi:10.1126/science.1060191 · Cited by 1,281

Strategies to improve radiotherapy with targeted drugs

Begg, A. C., Stewart, F. A., & Vens, C. (2011) · Nature reviews. Cancer · doi:10.1038/nrc3007 · Cited by 1,155

Balancing the activation state of the endothelium via two distinct TGF‐β type I receptors

Goumans, M., Valdimarsdóttir, G., Itoh, S., Rosendahl, A., Sideras, P., & ten Dijke, P. (2002) · The EMBO Journal · doi:10.1093/emboj/21.7.1743 · Cited by 1,127

Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck

Brizel, D. M., Sibley, G. S., Prosnitz, L. R., Scher, R. L., & Dewhirst, M. W. (1997) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(97)00101-6 · Cited by 1,075

Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial

Stupp, R., Hegi, M. E., Gorlia, T., Erridge, S. C., Perry, J., Hong, Y.-K., Aldape, K. D., Lhermitte, B., Pietsch, T., Grujicic, D., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70379-1 · Cited by 1,052

Immune-Mediated Inhibition of Metastases after Treatment with Local Radiation and CTLA-4 Blockade in a Mouse Model of Breast Cancer

Demaria, S., Kawashima, N., Yang, A. M., Devitt, M. L., Babb, J. S., Allison, J. P., & Formenti, S. C. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.728.11.2 · Cited by 1,027

Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors

Moeller, B. J., Cao, Y., Li, C. Y., & Dewhirst, M. W. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00115-1 · Cited by 996

Autocrine TGF-β and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts

Kojima, Y., Acar, A., Eaton, E. N., Mellody, K. T., Scheel, C., Ben‐Porath, I., Önder, T. T., Wang, Z. C., Richardson, A. L., Weinberg, R. A., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1013805107 · Cited by 894

Anti-PD-1 Blockade and Stereotactic Radiation Produce Long-Term Survival in Mice With Intracranial Gliomas

Zeng, J., See, A. P., Phallen, J., Jackson, C. M., Belcaid, Z., Ruzevick, J., Durham, N., Meyer, C., Harris, T. J., Albesiano, E., et al. (2013) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2012.12.025 · Cited by 889

Caspase 3–mediated stimulation of tumor cell repopulation during cancer radiotherapy

Huang, Q., Li, F., Liu, X., Li, W., Shi, W., Liu, F.-F., O'Sullivan, B., He, Z., Peng, Y., Tan, A.-C., et al. (2011) · Nature Medicine · doi:10.1038/nm.2385 · Cited by 886

The Efficacy of Radiotherapy Relies upon Induction of Type I Interferon–Dependent Innate and Adaptive Immunity

Burnette, B., Liang, H. L., Lee, Y., Chlewicki, L. K., Khodarev, N. N., Weichselbaum, R. R., Fu, Y., & Auh, S. L. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2820 · Cited by 883

Tumor-infiltrating NY-ESO-1–specific CD8 + T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer

Matsuzaki, J., Gnjatic, S., Mhawech-Fauceglia, P., Beck, A., Miller, A., Tsuji, T., Eppolito, C., Qian, F., Lele, S., Shrikant, P., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003345107 · Cited by 859

Exhaustion of tumor-specific CD8+ T cells in metastases from melanoma patients

Baitsch, L., Baumgaertner, P., Devêvre, E., Raghav, S. K., Legat, A., Barba, L., Wieckowski, S., Bouzourene, H., Deplancke, B., Romero, P., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci46102 · Cited by 845

Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression

Spaeth, E. L., Dembinski, J. L., Sasser, A. K., Watson, K., Klopp, A., Hall, B., Andreeff, M., & Marini, F. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004992 · Cited by 807

Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice

Kioi, M., Vogel, H. S., Schultz, G. M., Hoffman, R. M., Harsh, G. R., & Brown, J. M. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40283 · Cited by 778

Radiation-Induced CXCL16 Release by Breast Cancer Cells Attracts Effector T Cells

Matsumura, S., Wang, B., Kawashima, N., Braunstein, S. E., Badura, M. L., Cameron, T. O., Babb, J. S., Schneider, R. J., Formenti, S. C., Dustin, M. L., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.5.3099 · Cited by 731

Tumor microenvironment: The role of the tumor stroma in cancer

Li, H., Fan, X., & Houghton, J. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21159 · Cited by 646

Pathogenetic mechanisms in radiation fibrosis

Yarnold, J. R., & Vozenin, M. (2010) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2010.09.002 · Cited by 643

Inflammation as a Tumor Promoter in Cancer Induction

Philip, M., Rowley, D. A., & Schreiber, H. (2004) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2004.06.006 · Cited by 640

Immunostimulatory monoclonal antibodies for cancer therapy

Melero, I., Hervás‐Stubbs, S., Glennie, M. J., Pardoll, D. M., & Chen, L. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2051 · Cited by 634

Multifunctional Albumin–MnO2 Nanoparticles Modulate Solid Tumor Microenvironment by Attenuating Hypoxia, Acidosis, Vascular Endothelial Growth Factor and Enhance Radiation Response

Prasad, P., Gordijo, C. R., Abbasi, A. Z., Maeda, A., Ip, A., Rauth, A. M., DaCosta, R. S., & Wu, X. Y. (2014) · ACS Nano · doi:10.1021/nn405773r · Cited by 633

Targeting the TGFβ pathway for cancer therapy

Neuzillet, C., Tijeras‐Raballand, A., Cohen, R., Cros, J. F., Faivre, S. J., Raymond, É., & Gramont, A. D. E. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.11.001 · Cited by 631

Untitled work

(2001) · PubMed · Cited by 605

A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85

Overgaard, J., Hansen, H. S., Overgaard, M., Bastholt, L., Berthelsen, A., Specht, L., Lindeløv, B., & Jørgensen, K. J. (1998) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(97)00220-x · Cited by 575

A Phase I Study of OncoVEXGM-CSF, a Second-Generation Oncolytic Herpes Simplex Virus Expressing Granulocyte Macrophage Colony-Stimulating Factor

Hu, J. C. C., Coffin, R. S., Davis, C. J., Graham, N. J., Groves, N., GUEST, P. J., Harrington, K. J., James, N. D., Love, C., McNeish, I. A., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0759 · Cited by 571

Radiation-Induced Vascular Damage in Tumors: Implications of Vascular Damage in Ablative Hypofractionated Radiotherapy (SBRT and SRS)

Park, H. J., Griffin, R. J., Hui, S. K., Levitt, S. H., & Song, C. W. (2012) · Radiation Research · doi:10.1667/rr2773.1 · Cited by 550

Tumour immunity: effector response to tumour and role of the microenvironment

Mantovani, A., Romero, P. J., Palucka, A. K., & Marincola, F. M. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60241-x · Cited by 539

Irradiated mammary gland stroma promotes the expression of tumorigenic potential by unirradiated epithelial cells.

Barcellos‐Hoff, M. H., & Ravani, S. A. (2000) · PubMed · Cited by 536

Transforming growth factor-β and fibrosis

Verrecchia, F., & Mauviel, A. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i22.3056 · Cited by 531

Evidence for acutely hypoxic cells in mouse tumours, and a possible mechanism of reoxygenation

Brown, J. M. (1979) · British Journal of Radiology · doi:10.1259/0007-1285-52-620-650 · Cited by 527

Sonic Hedgehog Promotes Desmoplasia in Pancreatic Cancer

Bailey, J. M., Swanson, B. J., Hamada, T., Eggers, J. P., Singh, P. K., Caffrey, T. C., Ouellette, M. M., & Hollingsworth, M. A. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0291 · Cited by 520

Induction of alpha-smooth muscle actin by transforming growth factor-beta 1 in quiescent human breast gland fibroblasts. Implications for myofibroblast generation in breast neoplasia.

Rønnov‐Jessen, L., & PETERSEN, O. W. (1993) · PubMed · Cited by 514

Radiation and the microenvironment – tumorigenesis and therapy

Barcellos‐Hoff, M. H., Park, C., & Wright, E. G. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1735 · Cited by 513

Hypoxic Modification of Radiotherapy in Squamous Cell Carcinoma of the Head and Neck - A Systematic Review and Meta-Analysis

Overgaard, J. (2011) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2011.03.004 · Cited by 456

Cancer-Associated Fibroblasts as Another Polarized Cell Type of the Tumor Microenvironment

Augsten, M. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00062 · Cited by 446

Radiotherapy Promotes Tumor-Specific Effector CD8+ T Cells via Dendritic Cell Activation

Gupta, A. K., Probst, H. C., Vuong, V., Landshammer, A., Muth, S., Yagita∥, H., Schwendener, R. A., Pruschy, M. N., Knuth, A. K., & van den Broek, M. F. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200563 · Cited by 446

Restoration of the immunogenicity of cisplatin-induced cancer cell death by endoplasmic reticulum stress

Martins, I., Kepp, O., Schlemmer, F., Adjemian, S., Tailler, M., Shen, S., Michaud, M., Menger, L., Gdoura, A., Tajeddine, N., et al. (2010) · Oncogene · doi:10.1038/onc.2010.500 · Cited by 443

Radiation Enhances Regulatory T Cell Representation

Kachikwu, E. L., Iwamoto, K. S., Liao, Y., DeMarco, J. J., Agazaryan, N., Economou, J. S., McBride, W. H., & Schaue, D. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.09.034 · Cited by 439

Transforming growth factor-beta activation in irradiated murine mammary gland.

Barcellos‐Hoff, M. H., Derynck, R., Tsang, M., & Weatherbee, J. A. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117045 · Cited by 428

The Abscopal Effect Associated With a Systemic Anti-melanoma Immune Response

Stamell, E. F., Wolchok, J. D., Gnjatic, S., Lee, N. Y., & Brownell, I. (2013) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2012.03.017 · Cited by 387

Inhibition of PDGF, VEGF and FGF signalling attenuates fibrosis

Chaudhary, N. I., Roth, G. J., Hilberg, F., Müller–Quernheim, J., Prasse, A., Zissel, G., Schnapp, A., & Park, J. E. (2007) · European Respiratory Journal · doi:10.1183/09031936.00152106 · Cited by 386

Radiation to Stromal Fibroblasts Increases Invasiveness of Pancreatic Cancer Cells through Tumor-Stromal Interactions

Ohuchida, K., Mizumoto, K., Murakami, M., Qian, L.-W., Sato, N., Nagai, E., Matsumoto, K., Nakamura, T., & Tanaka, M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2464 · Cited by 385

Combining radiotherapy and immunotherapy: A revived partnership

Demaria, S., Bhardwaj, N., McBride, W. H., & Formenti, S. C. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.06.032 · Cited by 376

Induction of MET by Ionizing Radiation and Its Role in Radioresistance and Invasive Growth of Cancer

Bacco, F. D., Luraghi, P., Médico, E., Reato, G., Girolami, F., Perera, T. P. S., Gabriele, P., Comoglio, P. M., & Boccaccio, C. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr093 · Cited by 374

Origins of the tumor microenvironment: quantitative assessment of adipose-derived and bone marrow-derived stroma

Kidd, S., Spaeth, E., Watson, K., Burks, J., Lu, H., Klopp, A., Andreeff, M., & Marini, F. C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030563 · Cited by 371

Combining a Recombinant Cancer Vaccine with Standard Definitive Radiotherapy in Patients with Localized Prostate Cancer

Gulley, J. L., Arlen, P. M., Bastian, A., Morin, S., Marté, J. L., Beetham, P. K., Tsang, K.-Y., Yokokawa, J., Hodge, J. W., Ménard, C. M., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2062 · Cited by 370

Targeted antiangiogenic therapy for cancer using Vitaxin: a humanized monoclonal antibody to the integrin alphavbeta3.

Gutheil, J. C., Campbell, T. N., Pierce, P. R., Watkins, J. D., Huse, W. D., Bodkin, D., & Cheresh, D. A. (2000) · PubMed · Cited by 369

Hypoxia-inducible factor (HIF1A and HIF2A), angiogenesis, and chemoradiotherapy outcome of squamous cell head-and-neck cancer

Koukourakis, M. I., Giatromanolaki, A., Sivridis, E., Simopoulos, C., Turley, H., Talks, K., Gatter, K. C., & Harris, A. L. (2002) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)02848-1 · Cited by 361

Inhibition of TGF-β with neutralizing antibodies prevents radiation-induced acceleration of metastatic cancer progression

Biswas, S., Guix, M., Rinehart, C., Dugger, T. C., Chytil, A. M., Moses, H. L., Freeman, M. L., & Arteaga, C. L. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30740 · Cited by 346

Hedgehog signaling regulates epithelial-mesenchymal transition during biliary fibrosis in rodents and humans

Omenetti, A., Porrello, A., Jung, Y., Yang, L., Popov, Y. V., Choi, S. S., Witek, R. P., Alpini, G. D., Venter, J., VanDongen, H. M. A., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35875 · Cited by 346

Transforming growth factor-beta1 induces desmoplasia in an experimental model of human pancreatic carcinoma.

Löhr, M. J., Schmidt, C., Ringel, J., Kluth, M., Müller, P., Nizze, H., & Jesnowski, R. (2001) · PubMed · Cited by 323

Phase 1 Study of Stereotactic Body Radiotherapy and Interleukin-2—Tumor and Immunological Responses

Seung, S. K., Curti, B. D., Crittenden, M. R., Walker, E., Coffey, T. S., Siebert, J., Miller, W. L., Payne, R., Glenn, L. A., Bageac, A., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003649 · Cited by 307

Endogenous Markers of Two Separate Hypoxia Response Pathways (hypoxia inducible factor 2 alpha and carbonic anhydrase 9) Are Associated With Radiotherapy Failure in Head and Neck Cancer Patients Recruited in the CHART Randomized Trial

Koukourakis, M. I., Bentzen, S. M., Giatromanolaki, A., Wilson, G. D., Daley, F. M., Saunders, M. I., Dische, S., Sivridis, E., & Harris, A. L. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.7474 · Cited by 289

Scheduling of Radiation with Angiogenesis Inhibitors Anginex and Avastin Improves Therapeutic Outcome via Vessel Normalization

Dings, R. P. M., Loren, M. L., Heun‐Johnson, H., McNiel, E. A., Griffioen, A. W., Mayo, K. H., & Griffin, R. J. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2441 · Cited by 287

Ionizing Radiation Accelerates the Development of Atherosclerotic Lesions in ApoE−/− Mice and Predisposes to an Inflammatory Plaque Phenotype Prone to Hemorrhage

Stewart, F. A., Heeneman, S., Poele, J. A. M. T., Kruse, J. J. C. M., Russell, N. S., Gijbels, M. J., & Daemen, M. J. A. P. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.050409 · Cited by 286

Recruitment of Myeloid but not Endothelial Precursor Cells Facilitates Tumor Regrowth after Local Irradiation

Kozin, S. V., Kamoun, W. S., Huang, Y., Dawson, M., Jain, R. K., & Duda, D. G. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4446 · Cited by 278

Abscopal regression of hepatocellular carcinoma after radiotherapy for bone metastasis

Ohba, K., Omagari, K., Nakamura, T., Ikuno, N., Saeki, S., Matsuo, I., Kinoshita, H., Masuda, J., Hazama, H., Sakamoto, I., et al. (1998) · Gut · doi:10.1136/gut.43.4.575 · Cited by 277

Connective tissue growth factor: a fibrogenic master switch in fibrotic liver diseases

Gressner, O. A., & Gressner, A. M. (2008) · Liver International · doi:10.1111/j.1478-3231.2008.01826.x · Cited by 275

Radiotherapy Increases the Permissiveness of Established Mammary Tumors to Rejection by Immunomodulatory Antibodies

Verbrugge, I., Hagekyriakou, J., Sharp, L. L., Gallí, M., West, A. C., McLaughlin, N. M., Duret, H., Yagita∥, H., Johnstone, R. W., Smyth, M. J., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0210 · Cited by 275

Inhibition of Integrin αvβ6, an Activator of Latent Transforming Growth Factor-β, Prevents Radiation-induced Lung Fibrosis

Puthawala, K., Hadjiangelis, N., Jacoby, S. C., Bayongan, E., Zhao, Z., Yang, Z., Devitt, M. L., Horan, G. S., Weinreb, P. H., Lukashev, M. E., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200706-806oc · Cited by 272

Inflammation-associated cancer: NF-κB is the lynchpin

Li, Q., Withoff, S., & Verma, I. M. (2005) · Trends in Immunology · doi:10.1016/j.it.2005.04.003 · Cited by 270

Targeting HER-2/ neu in Early Breast Cancer Development Using Dendritic Cells with Staged Interleukin-12 Burst Secretion

Czerniecki, B. J., Koski, G. K., Koldovsky, U., Xu, S., Cohen, P. A., Mick, R., Nisenbaum, H. L., Pasha, T., Xu, M., Fox, K. R., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4038 · Cited by 269

Phase I/II Study of Oncolytic HSVGM-CSF in Combination with Radiotherapy and Cisplatin in Untreated Stage III/IV Squamous Cell Cancer of the Head and Neck

Harrington, K. J., Hingorani, M., Tanay, M. A., Hickey, J., Bhide, S. A., Clarke, P. M., Renouf, L. C., Thway, K., Sibtain, A., McNeish, I. A., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0196 · Cited by 259

Accelerated Radiotherapy With Carbogen and Nicotinamide for Laryngeal Cancer: Results of a Phase III Randomized Trial

Janssens, G. O. R. J., Rademakers, S. E., Terhaard, C. H. J., Doornaert, P., Bijl, H. P., van den Ende, P. L. A., Chin, A., Marres, H. A. M., de Bree, R., van der Kogel, A. J., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.35.9315 · Cited by 259

The Response of the Microvascular System to Radiation: A Review

Baker, D. G., & Krochak, R. J. (1989) · Cancer Investigation · doi:10.3109/07357908909039849 · Cited by 258

Phase II Trial of Murine 131I-Labeled Antitenascin Monoclonal Antibody 81C6 Administered Into Surgically Created Resection Cavities of Patients With Newly Diagnosed Malignant Gliomas

Reardon, D. A. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.5.1389 · Cited by 257

A Systemic Complete Response of Metastatic Melanoma to Local Radiation and Immunotherapy

Hiniker, S. M., Chen, D. S., Reddy, S. A., Chang, D. T., Jones, J. C., Mollick, J. A., Swetter, S. M., & Knox, S. J. (2012) · Translational Oncology · doi:10.1593/tlo.12280 · Cited by 247

TGFβ1 Inhibition Increases the Radiosensitivity of Breast Cancer Cells In Vitro and Promotes Tumor Control by Radiation In Vivo

Bouquet, F., Pal, A., Pilones, K. A., Demaria, S., Hann, B. C., Akhurst, R. J., Babb, J. S., Lonning, S. M., DeWyngaert, J. K., Formenti, S. C., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0544 · Cited by 247

Significance of Heparanase in Cancer and Inflammation

Vlodavsky, I., Beckhove, P., Lerner, I., Pisano, C., Meirovitz, A., Ilan, N., & Elkin, M. (2011) · Cancer Microenvironment · doi:10.1007/s12307-011-0082-7 · Cited by 246

Endostar, a novel recombinant human endostatin, exerts antiangiogenic effect via blocking VEGF-induced tyrosine phosphorylation of KDR/Flk-1 of endothelial cells

Ling, Y., Yang, Y., Lu, N., You, Q., Wang, S., Gao, Y., Chen, Y., & Guo, Q. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.06.155 · Cited by 246

Intratumoral hypoxia, radiation resistance, and HIF-1

Semenza, G. L. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00118-7 · Cited by 238

Regression of non-irradiated metastases after extracranial stereotactic radiotherapy in metastatic renal cell carcinoma

Wersäll, P. J., Blomgren, H., Pisa, P., Lax, I., Kälkner, K., & Svedman, C. (2006) · Acta Oncologica · doi:10.1080/02841860600604611 · Cited by 233

A Phase I, Multicenter, Open-Label, First-in-Human, Dose-Escalation Study of the Oral Smoothened Inhibitor Sonidegib (LDE225) in Patients with Advanced Solid Tumors

Rodon, J. A., Tawbi, H. A.-H., Thomas, A., Stoller, R. G., Turtschi, C. P., Baselga, J. M., Sarantopoulos, J., Mahalingam, D., Shou, Y., Moles, M. A., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1710 · Cited by 230

Vascular Endothelium as the Vulnerable Element in Tumours

Denekamp, J. (1984) · Acta Radiologica Oncology · doi:10.3109/02841868409136015 · Cited by 224

Coxsackievirus B3 Is an Oncolytic Virus with Immunostimulatory Properties That Is Active against Lung Adenocarcinoma

Miyamoto, S., Inoue, H., Nakamura, T., Yamada, M., Sakamoto, C., Urata, Y., Okazaki, T., Marumoto, T., Takahashi, A., Takayama, K., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3185 · Cited by 222

β1 Integrin Inhibition Dramatically Enhances Radiotherapy Efficacy in Human Breast Cancer Xenografts

Park, C. C., Zhang, H. J., Yao, E. S., Park, C. J., & Bissell, M. J. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6390 · Cited by 220

Targeting Receptor Tyrosine Kinase MET in Cancer: Small Molecule Inhibitors and Clinical Progress

Cui, J. J. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm401427c · Cited by 216

Functional Relationship between Tumor-Associated Macrophages and Macrophage Colony-Stimulating Factor as Contributors to Cancer Progression

Laoui, D., Overmeire, E. V., BAETSELIER, P. D., Ginderachter, J. A. V., & Raes, G. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00489 · Cited by 207

Radiation, Inflammation, and Immune Responses in Cancer

Multhoff, G., & Radons, J. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00058 · Cited by 206

Pancreatic Stellate Cells Radioprotect Pancreatic Cancer Cells through β1-Integrin Signaling

Mantoni, T. S., Lunardi, S., Al‐Assar, O., Masamune, A., & Brunner, T. B. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-1633 · Cited by 206

Inhibition of αvβ3 Integrin Survival Signaling Enhances Antiangiogenic and Antitumor Effects of Radiotherapy

Abdollahi, A., Griggs, D. W., Zieher, H., Roth, A. K., Lipson, K. E., Saffrich, R., Gröne, H., Hallahan, D. E., Reisfeld, R. A., Debus, J., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1223 · Cited by 205

Significance of endothelial dysfunction in the pathogenesis of early and delayed radiation enteropathy

Wang, J., Boerma, M., Fu, Q., & Hauer‐Jensen, M. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i22.3047 · Cited by 202

Combination of Conformal Radiotherapy and Intratumoral Injection of Adoptive Dendritic Cell Immunotherapy in Refractory Hepatoma

Chi, K., Liu, S., Li, C., Kuo, H.-P., Wang, Y., Chao, Y., & Hsieh, S. (2005) · Journal of Immunotherapy · doi:10.1097/01.cji.0000154248.74383.5e · Cited by 188

β1-Integrin: A Potential Therapeutic Target in the Battle against Cancer Recurrence

Barkan, D., & Chambers, A. F. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0642 · Cited by 181

Oncolytic viruses: a novel form of immunotherapy

Prestwich, R. J. D., Harrington, K. J., Pandha, H., Vile, R. G., Melcher, A. A., & Errington‐Mais, F. (2008) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.8.10.1581 · Cited by 180

Guidelines for preclinical and early phase clinical assessment of novel radiosensitisers

Harrington, K. J., Billingham, L. J., Brunner, T. B., Burnet, N. G., Chan, C. S. K., Hoskin, P., Mackay, R. I., Maughan, T., Macdougall, J., McKenna, W. G., et al. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.240 · Cited by 177

Radiation-induced increase in invasive potential of human pancreatic cancer cells and its blockade by a matrix metalloproteinase inhibitor, CGS27023.

Qian, L.-W., Mizumoto, K., Urashima, T., Nagai, E., Maehara, N., Sato, N., Nakajima, M., & Tanaka, M. (2002) · PubMed · Cited by 166

How Can We Overcome Tumor Hypoxia in Radiation Therapy?

Harada, H. (2011) · Journal of Radiation Research · doi:10.1269/jrr.11056 · Cited by 164

PG545, a dual heparanase and angiogenesis inhibitor, induces potent anti-tumour and anti-metastatic efficacy in preclinical models

Dredge, K. S., Hammond, E., Handley, P., Gonda, T. J., Smith, M. T., Vincent, C., Brandt, R., Ferro, V., & Bytheway, I. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.11 · Cited by 163

Adjuvant Therapy With Agonistic Antibodies to CD134 (OX40) Increases Local Control After Surgical or Radiation Therapy of Cancer in Mice

Gough, M. J., Crittenden, M. R., Sarff, M., Pang, P., Seung, S. K., Vetto, J. T., Hu, H., Redmond, W. L., Holland, J. M., & Weinberg, A. D. (2010) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3181ee7095 · Cited by 159

Microvascular studies on the origins of perfusion-limited hypoxia.

Dewhirst, M. W., Kimura, H., Rehmus, W., Braun, R. D., Papahadjopoulos, D., Hong, K., & Secomb, T. W. (1996) · Europe PMC (PubMed Central) · Cited by 157

Microenvironment and Radiation Therapy

Yoshimura, M., Itasaka, S., Harada, H., & Hiraoka, M. (2012) · BioMed Research International · doi:10.1155/2013/685308 · Cited by 155

β1-integrin-mediated signaling essentially contributes to cell survival after radiation-induced genotoxic injury

Cordes, N., Seidler, J. F., Durzok, R., Geinitz, H., & Brakebusch, C. (2005) · Oncogene · doi:10.1038/sj.onc.1209164 · Cited by 155

Synergy of Topical Toll-like Receptor 7 Agonist with Radiation and Low-Dose Cyclophosphamide in a Mouse Model of Cutaneous Breast Cancer

Dewan, M. Z., Vanpouille‐Box, C., Kawashima, N., DiNapoli, S., Babb, J. S., Formenti, S. C., Adams, S., & Demaria, S. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0984 · Cited by 153

Radiation-induced apoptosis in microvascular endothelial cells

Langley, R. E., Bump, E. A., Quartuccio, S., Medeiros, D., & Braunhut, S. J. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.119 · Cited by 152

Phase II Trial of Murine 131I-Labeled Antitenascin Monoclonal Antibody 81C6 Administered Into Surgically Created Resection Cavities of Patients With Newly Diagnosed Malignant Gliomas

Reardon, D. A., Akabani, G., Coleman, R. E., Friedman, A. H., Friedman, H. S., Herndon, J. E., Cokgor, I., McLendon, R. E., Pegram, C. N., Provenzale, J. M., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.5.1389 · Cited by 152

Radiation-induced carotid artery atherosclerosis

Gujral, D. M., Chahal, N., Senior, R., Harrington, K. J., & Nutting, C. M. (2013) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2013.08.009 · Cited by 151

The Fibroblast Integrin α11β1 Is Induced in a Mechanosensitive Manner Involving Activin A and Regulates Myofibroblast Differentiation

Carracedo, S., Lü, N., Popova, S. N., Jonsson, R., Eckes, B., & Gullberg, D. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.078766 · Cited by 147

Single-Dose and Fractionated Irradiation Promote Initiation and Progression of Atherosclerosis and Induce an Inflammatory Plaque Phenotype in ApoE−/− Mice

Hoving, S., Heeneman, S., Gijbels, M. J., Poele, J. A. M. T., Russell, N. S., Daemen, M. J. A. P., & Stewart, F. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2008.02.031 · Cited by 146

ECM overrides DNA damage-induced cell cycle arrest and apoptosis in small-cell lung cancer cells through β1 integrin-dependent activation of PI3-kinase

Hodkinson, P. S., Elliott, T., Wong, W. S., Rintoul, R. C., MacKinnon, A. C., Haslett, C., & Sethi, T. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401849 · Cited by 144

Improved Intratumoral Oxygenation Through Vascular Normalization Increases Glioma Sensitivity to Ionizing Radiation

McGee, M. C., Hamner, J. B., Williams, R. F., Rosati, S. F., Sims, T. L., Ng, C. Y., Gaber, M. W., Calabrese, C. R., Wu, J., Nathwani, A. C., et al. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.12.010 · Cited by 144

Vascular Activation of Adhesion Molecule mRNA and Cell Surface Expression by Ionizing Radiation

Heckmann, M., Douwes, K., Peter, R. U., & Degitz, K. (1998) · Experimental Cell Research · doi:10.1006/excr.1997.3826 · Cited by 138

Phase I Trial Results of Iodine-131–Labeled Antitenascin Monoclonal Antibody 81C6 Treatment of Patients With Newly Diagnosed Malignant Gliomas

Cokgor, I., Akabani, G., Kuan, C., Friedman, H. S., Friedman, A. H., Coleman, R. E., McLendon, R. E., Bigner, S. H., Zhao, X.-G., Garcia-Turner, A. M., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.22.3862 · Cited by 136

Links between Innate Immunity and Normal Tissue Radiobiology

Schaue, D., & McBride, W. H. (2010) · Radiation Research · doi:10.1667/rr1931.1 · Cited by 134

Hedgehog pathway inhibitor saridegib (IPI-926) increases lifespan in a mouse medulloblastoma model

Lee, M. J., Hatton, B. A., Villavicencio, E. H., Khanna, P. C., Friedman, S. D., Ditzler, S. H., Pullar, B. J., Robison, K. E., White, K., Tunkey, C., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1114718109 · Cited by 134

A safety run‐in and randomized phase 2 study of cilengitide combined with chemoradiation for newly diagnosed glioblastoma (NABTT 0306)

Nabors, B., Mikkelsen, T., Hegi, M. E., Ye, X., Batchelor, T. T., Lesser, G. J., Peereboom, D. M., Rosenfeld, M. R., Olsen, J., Brem, S., et al. (2012) · Cancer · doi:10.1002/cncr.27585 · Cited by 132

Dual Inhibition of the PI3K/mTOR Pathway Increases Tumor Radiosensitivity by Normalizing Tumor Vasculature

Fokas, E., Im, J. H., Hill, S. A., Yameen, S., Stratford, M. R. L., Beech, J. S., Hackl, W., Maira, S.-M., Bernhard, E. J., McKenna, W. G., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-2263 · Cited by 131

Role of Radiation-induced TGF-beta Signaling in Cancer Therapy

Dancea, H. C. (2009) · Molecular and Cellular Pharmacology · doi:10.4255/mcpharmacol.09.06 · Cited by 126

Gamma-Ray Resistance of Regulatory CD4+CD25+Foxp3+ T Cells in Mice

Qu, Y., Jin, S., Zhang, A., Zhang, B., Shi, X.-Y., Wang, J.-J., & Zhao, Y. (2010) · Radiation Research · doi:10.1667/rr0978.1 · Cited by 125

Therapeutic synergy of TNP-470 and ionizing radiation: effects on tumor growth, vessel morphology, and angiogenesis in human glioblastoma multiforme xenografts.

Lund, E. L., Bastholm, L., & Kristjansen, P. E. G. (2000) · PubMed · Cited by 125

Novel insights into pathological changes in muscular arteries of radiotherapy patients

Russell, N. S., Hoving, S., Heeneman, S., Hage, J. J., Woerdeman, L. A. E., de Bree, R., Lohuis, P. J. F. M., Smeele, L. E., Cleutjens, J. P. M., Valenkamp, A., et al. (2009) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2009.05.021 · Cited by 121

Suramin: Clinical Uses and Structure-Activity Relationships

McGeary, R. P., Bennett, A. J., Tran, Q., Cosgrove, K. L., & Ross, B. P. (2008) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955708786369573 · Cited by 119

Combination of External Beam Radiotherapy (EBRT) With Intratumoral Injection of Dendritic Cells as Neo-Adjuvant Treatment of High-Risk Soft Tissue Sarcoma Patients

Finkelstein, S. E., Iclozan, C., Bui, M. M., Cotter, M. J., Ramakrishnan, R., Ahmed, J., Noyes, D. R., Cheong, D., González, R., Heysek, R. V., et al. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.12.068 · Cited by 115

Phase I trial of a Toll-like receptor 9 agonist, PF-3512676 (CPG 7909), in patients with treatment-refractory, cutaneous T-cell lymphoma

Kim, Y. H., Girardi, M., Duvic, M. A., Kuzel, T. M., Link, B. K., Pinter‐Brown, L. C., & Rook, A. H. (2010) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2009.12.052 · Cited by 115

Cancer-associated fibroblasts from human NSCLC survive ablative doses of radiation but their invasive capacity is reduced

Hellevik, T., Pettersen, I., Berg, V., Winberg, J., Moe, B. T., Bartnes, K., Paulssen, R. H., Busund, L., Bremnes, R. M., Chalmers, A. J., et al. (2012) · Radiation Oncology · doi:10.1186/1748-717x-7-59 · Cited by 115

A pilot study: 131I-Antitenascin monoclonal antibody 81c6 to deliver a 44-Gy resection cavity boost

Reardon, D. A., Zalutsky, M. R., Akabani, G., Coleman, R. E., Friedman, A. H., Herndon, J. E., McLendon, R. E., Pegram, C. N., Quinn, J. A., Rich, J. N., et al. (2008) · Neuro-Oncology · doi:10.1215/15228517-2007-053 · Cited by 112

The influence of microenvironmental factors during cancer therapy.

Durand, R. E. (1995) · PubMed · Cited by 112

IL-13 Induces Connective Tissue Growth Factor in Rat Hepatic Stellate Cells via TGF-β–Independent Smad Signaling

Liu, Y., Meyer, C., Müller, A., Herweck, F., Li, Q., Müllenbach, R., Mertens, P. R., Dooley, S., & Weng, H. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003260 · Cited by 111

Abscopal effect of radiation on lung metastases of hepatocellular carcinoma: a case report

Okuma, K., Yamashita, H., Niibe, Y., Hayakawa, K., & Nakagawa, K. (2011) · Journal of Medical Case Reports · doi:10.1186/1752-1947-5-111 · Cited by 109

Vasculogenesis: a crucial player in the resistance of solid tumours to radiotherapy

Brown, J. M. (2013) · British Journal of Radiology · doi:10.1259/bjr.20130686 · Cited by 107

Angiogenesis and tumor growth inhibition by a matrix metalloproteinase inhibitor targeting radiation-induced invasion

Kaliski, A., Maggiorella, L., Cengel, K. A., Mathé, D., Rouffiac, V., Opolon, P., Lassau, N., Bourhis, J., & Deutsch, É. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0179 · Cited by 95

Combining Radiation and Molecular Targeting in Cancer Therapy

Camphausen, K., & Tofilon, P. J. (2004) · Cancer Biology & Therapy · doi:10.4161/cbt.3.3.544 · Cited by 93

Potentiation of cytotoxic therapies by TNP-470 and minocycline in mice bearing EMT-6 mammary carcinoma

Teicher, B. A., Holden, S. A., Dupuis, N. P., Kakeji, Y., Ikebe, M., Emi, Y., & Goff, D. A. (1995) · Breast Cancer Research and Treatment · doi:10.1007/bf00666043 · Cited by 89

The Hallmarks of Cancer and the Radiation Oncologist: Updating the 5Rs of Radiobiology

Good, J., & Harrington, K. J. (2013) · Clinical Oncology · doi:10.1016/j.clon.2013.06.009 · Cited by 88

Lymphangiographic demonstration of the abscopal effect in patients with malignant lymphomas

Antoniades, J., Brady, L. W., & Lightfoot, D. A. (1977) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(77)90020-7 · Cited by 84

Radiotherapy augments the immune response to prostate cancer in a time‐dependent manner

Harris, T. J., Hipkiss, E. L., Borzillary, S., Wada, S., Grosso, J. F., Yen, H., Getnet, D., Bruno, T. C., Goldberg, M. V., Pardoll, D. M., et al. (2008) · The Prostate · doi:10.1002/pros.20794 · Cited by 84

Treatment regimen determines whether an HIF-1 inhibitor enhances or inhibits the effect of radiation therapy

Harada, H., Itasaka, S., Zhu, Y., Zeng, L., Xie, X., Morinibu, A., Shinomiya, K., & Hiraoka, M. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6604939 · Cited by 82

Tyrosine kinase inhibitors for the treatment of fibrotic diseases such as systemic sclerosis: towards molecular targeted therapies

Distler, J. H. W., & Distler, O. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.120196 · Cited by 70

Oxidative Stress Promotes Ligand-independent and Enhanced Ligand-dependent Tumor Necrosis Factor Receptor Signaling

Ozsoy, H. Z., Sivasubramanian, N., Wieder, E., Pedersen, S. E., & Mann, D. L. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802967200 · Cited by 67

Role of Heparanase in Radiation-Enhanced Invasiveness of Pancreatic Carcinoma

Meirovitz, A., Hermano, E., Lerner, I., Zcharia, E., Pisano, C., Peretz, T., & Elkin, M. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3402 · Cited by 67

Low-dose radiation augments vasculogenesis signaling through HIF-1–dependent and –independent SDF-1 induction

Lerman, O. Z., Greives, M. R., Singh, S. P., Thanik, V. D., Chang, C. C., Seiser, N., Brown, D. J., Knobel, D., Schneider, R. J., Formenti, S. C., et al. (2010) · Blood · doi:10.1182/blood-2009-03-213629 · Cited by 65

Mechanisms of heparanase inhibition by the heparan sulfate mimetic PG545 and three structural analogues

Hammond, E., Handley, P., Dredge, K. S., & Bytheway, I. (2013) · FEBS Open Bio · doi:10.1016/j.fob.2013.07.007 · Cited by 64

NIMRAD – A Phase III Trial to Investigate the Use of Nimorazole Hypoxia Modification with Intensity-modulated Radiotherapy in Head and Neck Cancer

Thomson, D. J., Yang, H., Baines, H., Miles, E. A., Bolton, S., West, C., & Slevin, N. J. (2014) · Clinical Oncology · doi:10.1016/j.clon.2014.03.003 · Cited by 64

Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrence

Liu, C. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i32.11384 · Cited by 64

Antitumor activity of TGF-beta inhibitor is dependent on the microenvironment.

Medicherla, S., Li, L., Jing, Y., Kapoun, A. M., Gaspar, N. J., Liu, Y.-W., Mangadu, R., O’Young, G., Protter, A. A., Schreiner, G. F., et al. (2007) · PubMed · Cited by 61

Skin Perfusion and Oxygenation Changes in Radiation Fibrosis

Chin, M. S., Freniere, B. B., Bonney, C. F., Lancerotto, L., Saleeby, J., Lo, Y., Orgill, D. P., FitzGerald, T. J., & Lalikos, J. F. (2013) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0b013e3182818b94 · Cited by 50

TNP-470/minocycline/cytotoxic therapy: A systems approach to cancer therapy

Teicher, B. A., Emi, Y., Kakeji, Y., & Northey, D. (1996) · European Journal of Cancer · doi:10.1016/s0959-8049(96)00380-2 · Cited by 50

Drug evaluation: Volociximab, an angiogenesis-inhibiting chimeric monoclonal antibody.

Kuwada, S. K. (2007) · PubMed · Cited by 49

Radiation as Immunomodulator: Implications for Dendritic Cell-Based Immunotherapy

Roses, R. E., Datta, J., & Czerniecki, B. J. (2014) · Radiation Research · doi:10.1667/rr13495.1 · Cited by 49

Improved Recurrence-Free Survival with ARCON for Anemic Patients with Laryngeal Cancer

Janssens, G. O. R. J., Rademakers, S. E., Terhaard, C. H. J., Doornaert, P., Bijl, H. P., van den Ende, P. L. A., Chin, A., Takes, R. P., de Bree, R., Hoogsteen, I. J., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1730 · Cited by 47

Synergistic cytotoxicity of radiation and oncolytic Lister strain vaccinia in V600D/EBRAF mutant melanoma depends on JNK and TNF-α signaling

Kyula, J., Khan, A., Mansfield, D., Karapanagiotou, E. M., McLaughlin, M., Roulstone, V., Zaidi, S. H. H., Pencavel, T. D., Touchefeu, Y., Seth, R., et al. (2013) · Oncogene · doi:10.1038/onc.2013.112 · Cited by 45

IN VIVO GLIOMA GROWTH REQUIRES HOST-DERIVED MATRIX METALLOPROTEINASE 2 FOR MAINTENANCE OF ANGIOARCHITECTURE

Takahashi, M., Fukami, S., Iwata, N., Inoue, K., Itohara, S., Itoh, H., Haraoka, J., & Saido, T. C. (2002) · Pharmacological Research · doi:10.1016/s1043-6618(02)00081-6 · Cited by 43

Suramin and radiotherapy in newly diagnosed glioblastoma: Phase 2 NABTT CNS Consortium study

Laterra, J., Grossman, S. A., Carson, K. A., Lesser, G. J., Hochberg, F. H., & Gilbert, M. R. (2004) · Neuro-Oncology · doi:10.1215/s1152851703000127 · Cited by 43

Accelerated Radiotherapy, Carbogen, and Nicotinamide (ARCON) in the Treatment of Advanced Bladder Cancer: Mature Results of a Phase II Nonrandomized Study

Hoskin, P., Rojas, A., & Saunders, M. I. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2008.06.1950 · Cited by 42

Radiation for Awakening the Dormant Immune System, a Promising Challenge to be Explored

de la Cruz‐Merino, L., Illescas-Vacas, A., pez, A. G.-L., Barco-Sánchez, A., & Míguez-Sánchez, C. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00102 · Cited by 40

Influence of bone marrow-derived hematopoietic cells on the tumor response to radiotherapy: Experimental models and clinical perspectives

Ahn, G., & Brown, J. M. (2009) · Cell Cycle · doi:10.4161/cc.8.7.8075 · Cited by 39

Ad.Egr-TNF and Local Ionizing Radiation Suppress Metastases by Interferon-β-Dependent Activation of Antigen-specific CD8+ T Cells

Meng, Y., Mauceri, H. J., Khodarev, N. N., Darga, T. E., Pitroda, S. P., Beckett, M. A., Kufe, D. W., & Weichselbaum, R. R. (2010) · Molecular Therapy · doi:10.1038/mt.2010.18 · Cited by 39

Suramin inhibits hepatic tissue damage in hepatocellular carcinoma through deactivation of heparanase enzyme

Tayel, A., Galil, K. H. A. E., Ebrahim, M., Ibrahim, A. S., El-Gayar, A. M., & Al-Gayyar, M. M. H. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.02.001 · Cited by 37

Radiation therapy alone or combined with misonidazole in the treatment of locally advanced non-oat cell lung cancer: Report of an rtog prospective randomized trial

Simpson, J. R., Bauer, M., Pérez, C. A., Wasserman, T. H., Emami, B., Doggett, R. L. S., Byhardt, R. W., Phillips, T. L., & Mowry, P. A. (1989) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(89)90953-x · Cited by 37

Oncolytic vaccinia virus in combination with radiation shows synergistic antitumor efficacy in pancreatic cancer

Dai, M., Liu, S. L., Chen, N. G., Zhang, T. P., You, L., Zhang, F., Chou, T., Szalay, A. A., Fong, Y., & Zhao, Y. P. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.11.007 · Cited by 32

Transforming growth factor-β and fibrosis

Franck, Verrecchia, Alain, & Mauviel (2007) · Acta Scientiarum Naturalium Universitatis Sunyatseni · Cited by 31

Inhibition of growth factor effects in retinal pigment epithelial cells.

Leschey, K. H., Hines, J., Singer, J. H., Hackett, S. F., & Campochiaro, P. A. (1991) · PubMed · Cited by 30

Phase I/II Trial of Sequential Chemoradiotherapy Using a Novel Hypoxic Cell Radiosensitizer, Doranidazole (PR-350), in Patients With Locally Advanced Non–Small-Cell Lung Cancer (WJTOG-0002)

Nishimura, Y., Nakagawa, K., Takeda, K., Tanaka, M., Segawa, Y., Tsujino, K., Negoro, S., Fuwa, N., Hida, T., Kawahara, M., et al. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.04.008 · Cited by 29

Radiotherapy and Toll-Like Receptor Agonists

Marabelle, A., Filatenkov, A., Sagiv-Barfi, I., & Kohrt, H. E. K. (2014) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2014.07.006 · Cited by 27

Myofibroblastic stromal reaction and lymph node status in invasive breast carcinoma: possible role of the TGF-β1/TGF-βR1 pathway

Catteau, X., Simon, P., & Noël, J. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-499 · Cited by 27

Antitumor activity of Endostar combined with radiation against human nasopharyngeal carcinoma in mouse xenograft models

Zhou, J., Wang, L., Xu, X., Tu, Y., Qin, S., & Yin, Y. (2012) · Oncology Letters · doi:10.3892/ol.2012.856 · Cited by 26

VEGF Regulates Region-Specific Localization of Perivascular Bone Marrow–Derived Cells in Glioblastoma

Burrell, K. E., Singh, S., Jalali, S., Hill, R. P., & Zadeh, G. M. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3119 · Cited by 26

ヘッジホッグ経路阻害剤,サリデギブ(IPI-926)はマウス髄芽腫モデルで寿命を延長する

Michelle, J. L., Beryl, A. H., Elisabeth, H. V., Paritosh, C. K., Seth, D. F., Ditzler, S. H., Pullar, B. J., Keith, R., Kerry, F. W., Tunkey, C., et al. (2012) · Cited by 22

Nintedanib (BIBF 1120) for IPF: a tomorrow therapy?

Antoniu, S. A. (2012) · Multidisciplinary Respiratory Medicine · doi:10.1186/2049-6958-7-41 · Cited by 21

The treatment of hepatic metastases from colorectal cancer with radiation therapy alone or combined with chemotherapy or misonidazole

Minsky, B. D., & Leibel, S. A. (1989) · Cancer Treatment Reviews · doi:10.1016/0305-7372(89)90042-x · Cited by 15

Endostar combined with radiotherapy increases radiation sensitivity by decreasing the expression of TGF-β1, HIF-1α and bFGF

Wu, Y.-G., Zheng, Y., Shen, Z., Ge, W., Xie, Y.-S., & Li, C. (2014) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2014.1526 · Cited by 15

Positive clinical experience with misonidazole in brachytherapy and external radiotherapy

Baillet, F., Housset, M., Dessard-Diana, B., & Boisserie, G. (1989) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(89)90919-x · Cited by 12

Abrogation of TGF-β by antisense oligonucleotides modulates expression of VEGF and increases angiogenic potential in isolated fibroblasts from radiated skin

Riedel, V. (1998) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000045 · Cited by 9

Treatment of margin positive basal cell carcinoma with vismodegib: case report and consideration of treatment options and their implications.

Bayers, S., Kapp, D. L., Beer, K. R., & Slavin, B. R. (2013) · PubMed · Cited by 8

Pilot Trial of Radiation Therapy and GM-CSF in Metastatic Cancer: Abscopal Responses

Formenti, S. C., Adams, S., Friedman, K. P., Fenton-Kerimian, M., Donach, M. E., Goldberg, J. D., & Demaria, S. (2012) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2012.07.461 · Cited by 6

Inflammation and tumor progression: signaling pathways and targeted intervention

Zhao, H., Wu, L., Yan, G., Chen, Y., Zhou, M., Wu, Y., & Li, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00658-5 · Cited by 3,058

Reactive Oxygen Species (ROS)-Based Nanomedicine

Yang, B., Chen, Y., & Shi, J. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00626 · Cited by 2,477

Targeting macrophages: therapeutic approaches in cancer

Cassetta, L., & Pollard, J. W. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.169 · Cited by 2,086

The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy

Bruni, D., Angell, H. K., & Galon, J. (2020) · Nature reviews. Cancer · doi:10.1038/s41568-020-0285-7 · Cited by 1,586

Mitotic progression following DNA damage enables pattern recognition within micronuclei

Harding, S. M., Benci, J. L., Irianto, J., Discher, D. E., Minn, A. J., & Greenberg, R. A. (2017) · Nature · doi:10.1038/nature23470 · Cited by 1,508

Targeting Tumor Microenvironment and Metabolism to Overcome Radiation Resistance

Sharma, A., & Pruschy, M. N. (2018) · Progress in tumor research · doi:10.1159/000486986 · Cited by 2

The tumor microenvironment as a key regulator of radiotherapy response

Ma, X., & Zhang, N. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1776636 · Cited by 2

Radiation-induced tumor immune microenvironments and potential targets for combination therapy

Guo, S., Yao, Y., Tang, Y., Xin, Z., Wu, D., Ni, C., Huang, J., Wei, Q., & Zhang, T. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01462-z · Cited by 290

Targeting Tumor Physical Microenvironment for Improved Radiotherapy

Wang, J., Han, Y., Li, Y., Zhang, F., Cai, M., Zhang, X., Chen, J., Ji, C., Ma, J., & Xu, F. (2022) · Small Methods · doi:10.1002/smtd.202200570 · Cited by 36

Radiation Response in the Tumour Microenvironment: Predictive Biomarkers and Future Perspectives

Byrne, N. M., Tambe, P., & Coulter, J. A. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11010053 · Cited by 21